Close menu

• A weight loss of 5.5kg measured at 16 weeks of treatment in people with type 1 diabetes and a body mass index greater than 30kg/m2
• Glycemic control efficacy comparable to that obtained with the commercial reference insulin Humalog® (Eli Lilly)
• These results were presented at the 58th European Association for the Study of Diabetes (EASD) Annual Meeting held in Stockholm from September 19 to 23, 2022


Read the press release

More information